Dementia

Researchers evaluated the efficacy of low-dose oral tetrahydrocannabinol treatment in individuals with dementia-related neuropsychiatric symptoms.

Researchers at the Mayo Clinic have identified a very simple new scoring system that may be helpful in predicting which elderly patients are at risk of developing mild cognitive impairment.

Researchers have developed a new, simple, inexpensive test to measure symptoms of pre-dementia.